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ABSTRACT 
Patient safety is one of the most important health care challenges. It is a big concern since 
1 in every 10 patients around the world is affected by healthcare errors. The focus of this study is 
given to preventable adverse events that caused by the errors or system flaw that could have been 
avoided. In this study, simulation models are developed using Arena to evaluate the impact of 
GS1 data standards on patient risk in healthcare supply chain. The focus was given to the 
provider hospital supply chain operations where inventory discrepancy and performance 
deficiencies in recall, return, and outdate management can directly affect patient safety. 
Simulation models are developed for various systems and scenarios to compare different 
performance measures and analyze the impact of GS1. The results indicates that as the validation 
points are closer to the point of use, the number of recalled or outdated products administered to 
a patient are still reduced significantly so checking at the bedside or PAR is critical. But 
validation only at these points may cause some problems such as stock outs; therefore, validating 
in other locations is also needed. 
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CHAPTER 1 
INTRODUCTION 
Patient safety is one of the most important health care challenges. It is a big concern since 
1 in every 10 patients around the world is affected by healthcare errors (Wen, 2008). Patient 
safety is defined as an issue in healthcare that tries to minimize the occurrence and influence of 
adverse events (also called patient safety events) and maximize recovery from them (Emanuel et 
al., 2008). An adverse event in healthcare is defined as an injury caused by medical management 
rather than by the underlying disease or condition of the patients (Tsilimingras, n.d.). Adverse 
events can be classified in different ways; in the context of this study, they are categorized as 
follows: (1) non-preventable adverse events, such as a first time allergic reaction to a drug and 
(2) preventable adverse events, such as a wrong dose of a medicine administered to a patient. 
Even though non-preventable adverse events have greater potential of morbidity and mortality, 
preventable adverse events offer better opportunities to learn and improve patient safety. These 
opportunities include identifying adverse events, analyzing their courses, and taking corrective 
actions to reduce the reoccurrence of similar events (Sasou and Reason 1999).  
Preventable adverse events, which are the focus of this study, are defined as injuries, 
caused by an error or system flaw that could have been avoided. There are many terms in the 
literature that are relevant to patient safety. Among them, errors are the occurrences that do not 
necessarily harm patients and include other terms such as mistakes, near misses, active errors, 
and latent errors. Near misses are unplanned events that do not result in injury but have the 
potential to do so. An example of no harm or minor harm is administering an extra strength drug 
by mistake and an example of a serious injury and even death is performing a surgical procedure 
on a wrong patient (Ginsburg et al., 2009). Active errors typically occur when a patient interacts 
 2 
 
with nurses. Examples of active errors include infections due to contaminated equipment or 
devices, using expired or recalled device or drugs, catheter-acquired infections (Attarian, 2008), 
and using a device for functions other than as intended due to misidentification. Latent errors 
include system defects such as poor design, incorrect installation, faulty maintenance of 
equipment and devices, poor purchasing decisions, and inadequate staffing (Thomas et al., 
2003). Latent errors and active errors are main causes of adverse events that typically harm 
patients and causes injuries or damages. 
A comprehensive study by Elder and Dovey (2002) classifies preventable adverse events 
in primary care in three groups: (1) diagnosis incidents, (2) treatment incidents, and (3) 
preventive service incidents. Diagnosis incidents typically include symptom or prevention-
related missed diagnosis and delayed diagnosis. Treatment incidents may be drug-related cases 
such as administering incorrect drug, incorrect dose, delayed or omitted administration or non-
drug-related cases such as inappropriate, delayed or omitted clinical actions, as well as 
procedural complications. Preventive service incidents are similar to the non-drug-related 
treatment cases. They too include inappropriate, delayed or omitted actions, and procedural 
complications but for preventive services. 
The same study classifies the reasons of these events as follows: (1) clinician factors, (2) 
communication factors, (3) administration factors, and (4) blunt-end factors (Elder and Dovey, 
2002). Clinician factors contain clinical judgment and procedural skill errors such as prescribing 
an incorrect drug to a patient. Communication factors, which are over half of the serious adverse 
events, include inadequate communication between healthcare providers or clinicians, as well as 
between clinicians and patients or family members. Any types of cultural or language barriers 
are examples of these factors. Administration factors typically are administrative problems in 
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clinician, pharmacy, ancillary provider (e.g. physical therapy) or office settings. For example, 
missing medical history of a patient or losing information. The last group is blunt-end factors 
which include personnel and family issues of clinicians and staff, government or insurance 
company regulations, size and location of practice, and general healthcare delivery systems-
related issues.  
Adverse event statistics over the years reveal enormous and astonishing number of errors. 
A study on adverse events by Troyen et al. (1991) analyzes hospitalizations in the state of New 
York in 1984 and reports that 3.7 percent of hospital patients experienced adverse events and 
27.6 percent of those involved negligence. The same study indicates that over 70 percent of 
adverse events causes disability lasting less than 6 months, 2.6 percent results in permanent 
disability, and 13.6 percent of these events results in death. Another study by Thomas et al. 
(2000) estimates the incidence and types of adverse events in Utah and Colorado and reports the 
results similar to the previous study. The study finds that 2.9 percent of hospital patients 
experiences adverse events and 6.6 percent of them causes death. In Utah, 32.6 percent of 
adverse events are due to negligence whereas in Colorado it is 27.4 percent. (Thomas et al., 
2000). Figure 1 illustrates the number of adverse event reports received by the U.S. Food and 
Drug Administration (FDA) Adverse Events Reporting System (FAERS) in different years.  
 4 
 
 
Figure 1: Number of adverse events reported by calendar year (FDA, 2010) 
Among many of the adverse events, supply chain-related issues are one of the major 
reasons for adverse events in healthcare settings. The majority of the supply chain-related issues 
are caused by inventory discrepancy and performance deficiencies in recall, return, and outdate 
management at the provider’s level. A Harvard study shows that 19.4% of adverse events are 
caused by medication errors and over 60% of these medication errors are because of using  the 
wrong drug or wrong dosage (Jenkins et al., 2007). Implementing standard product and 
partner/location identification enables suppliers and buyers to identify and navigate the product 
along the chain. Therefore, implementing these standards ensures correct products are delivered 
to correct locations, correct patient, avoiding the adverse events and leading to an increase in 
patient safety (Kritchanchai, 2012). In addition to misidentification errors that occur during the 
supply chain operations, there are other issues that can impact patient safety. Inventory accuracy 
is observed when the recorded perpetual balance of a product varies from the actual on-hand 
quantity. Product misplacement and mispicking during replenishment operations as well as 
shrinkage (theft), and transaction errors are major sources of inventory discrepancy. These errors 
lead to stock outs and as a result delay in providing care (Opolon, 2010). Global data standards 
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reduce these inventory errors, improve record keeping, improve stock rotation for products, 
improve efficiency, and reduce stock outs (Bix et al., 2007). Standardized product and 
partner/location data improves product traceability and reduce the lack of supply visibility (thus 
shortage of physical inventory). Tracking products helps to improve the performance 
deficiencies and problems in recall and outdate managements. Faster to find and remove recalled 
products, more efficient to close recall cases, less time for unsafe products to be available, so less 
time for harming patients (Jenkins et al., 2007). A study by Tucker (2004), shows that 9% of 
total nursing time spent on resolving operational failures and 55% of these failures originate 
outside the nursing units and many of them are linked to supply items. Therefore, insufficient 
product availability is a frequent problem in hospitals and leads to additional nursing, delayed 
procedures, and workflow interruptions that put patients at risk (Tucker and Spear, 2006).  
In addition to inventory accuracy, performance deficiencies and problems in recall, 
return, and outdate management are important causes of supply chain related issues that affect 
patient safety in healthcare settings. Food and Drug Administration (FDA) states that any action 
taken to address a problem with a product that violates FDA laws is defined recall (FDA, 2011a). 
Recalls occur when a product is defective, or it is unsafe to use and harmful for health, or both. 
There are well defined and detailed identification, removal, and return procedures and processes 
during a recall at the hospitals, which will be discussed in the next sections. In case of outdate, 
the product is no longer valid or safe to use. Unlike recalls, not every hospital has well defined 
and detailed procedures for outdated products. Furthermore, monitoring the inventory at different 
stages and checking for outdated products is a continuous process in the supply chain. Once an 
outdated product is caught during continuous monitoring, it is removed from the system as soon 
as possible to avoid any adverse events. Standardized product and partner/location identifier 
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technologies are emerging, as the long needed approach, to reduce error rates in product 
identification and expired/recalled product location while moving the products in the supply 
chain and administering them to the patients. These improvements lead to better inventory 
visibility in the supply chain as well as efficient product identification and removal; thus, 
decreased patient risk and increased patient safety. (Jayaraman et al., 2011). As Mr. Kenshi 
Kinoshita (Director of the Ministry of health, labor and welfare’s Economic Affairs Division in 
Japan) points out, the use of standardized data not only ensures patient safety as it prevents 
medical errors, but also offers advantages in terms of efficiencies and the overall management of 
medical organizations (Kreysa, 2008).  
Globally accepted Global Standards 1 (GS1) Data Standards provide unique, 
unambiguous identifiers for product and partner/location identification as an answer to that need. 
GS1 Data Standards are the essential building blocks for efficient information, product and cash 
flow (Hubner and Elmhorst, 2008). They also provide a critical foundation for increased quality 
of care as well as reduced cost and patient risk. The basic set of GS1 identification standards 
include Global Trade Item Number (GTIN) for product identification, the Global Location 
Number (GLN) for trading partner identification and the Global Data Synchronization Network 
(GDSN) provides a synchronization mechanism for sharing accurate product information 
between manufacturers, distributors, group purchasing organizations (GPOs) and healthcare 
providers (Jayaraman et al., 2011). 
This study investigates the impact of using standard product and partner/location 
identifying data on inventory accuracy as well as recall, return, and outdates management 
policies in healthcare supply chain. Standard product identification information also includes 
production data such as expiration dates and lot/serial numbers on products to facilitate efficient 
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management policies while reducing patient risk and increasing safety by eliminating the 
opportunities of adverse events. The focus in this study is given to the provider hospital supply 
chain operations where inventory discrepancy and performance deficiencies in recall, return, and 
outdate management can directly affect patient safety. Simulation models are developed for 
various scenarios to compare the performance of different recall, return, and outdate 
management policies and procedures, and to suggest the best practices. Tested policies and 
procedures are confirmed and validated by a number of healthcare provider hospitals. The details 
of the preliminary studies are discussed in the next section. Inventory accuracy, supply chain 
process error rates, product identification and removal efficiency in recall and outdate 
management processes, and patient risk are considered as the basis of comparison. 
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CHAPTER 2 
BACKGROUND 
Many of the supply chain related issues that cause adverse events occur at the point of 
care (POC), typically during the product administration, where is it easier to catch and/or prevent 
because they are typically limited in time and space.  Thirty four percent of all medication errors 
that cause problems for patients are associated with drug administration (Jenkins et al., 2007). 
The majority of these issues are active errors or near misses and can be caught by error reporting 
systems, administrative data analysis, chart reviews, electronic medical record reviews, 
observation of patient care, or clinical surveillance (Thomas et al., 2003). Some of these methods 
require continuous monitoring of products while some may be triggered after an incident.  
 Recalls are one of most serious problems in patient safety. Recall management is costly 
for the manufacturer as well as the healthcare provider because all the recalled products have to 
be located in the system, returned, and replenished. According to Product Recall Research Group 
at the University of New Mexico, the danger of unsafe products always exists in healthcare; 
however, recalls can be managed well by taking proper actions and lives can be saved (CPSC 
Works..., 1997, 1). FDA classifies product recalls based on the risk it can cause to public health 
as follows: Class I (High risk), Class II (less-serious risk), and Class III (low risk). In a Class I 
recall, there is a chance of serious health problems or death due to the effect of recalled product. 
A Class II recall is not as serious as Class I recall, but still there is a possibility of health issues. 
A Class III recall represents a less-serious risk. In a Class III recall, the chance of health 
problems by using the product is low (FDA, 2011a). The number of medical and radiation 
emitting device recalls by their type is given in Table 1.  
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Table 1: Recall type statistics per year, (FDA, 2011b)  
 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012* 
Class I 30 61 65 65 44 140 160 426 301 126 
Class II 848 1315 1295 1282 1183 2184 2076 2288 2385 2040 
Class III 183 205 192 202 113 166 172 106 120 113 
Until November 2012 
The recall process typically starts with the issue for recall by a manufacturer. Then 
providers receive alerts through FDA’s website or by the manufacturer, and start handling the 
recall. There are also some notification management services, such as RASMAS and ECRI that 
notify providers for recalls (Runy, 2007). Manufacturers take actions based on the above-
mentioned recall classification; in a Class I recall, the manufacturer notifies its customers (e.g. 
distributors or vendors) and directs them to notify the intended recipients of the recalled product 
(e.g. other vendors, hospitals, nursing homes, outpatient treatment facilities, doctors, or 
individual patients). The manufacturer also issues a press release to notify the public, if 
appropriate, to minimize health consequences. In a Class II recall, the manufacturer informs its 
clients and sometimes asks them to notify the intended recipients (FDA, 2009; FDA, 2011a). 
Since Class I cases are serious threats for health, there are regulations related for alerting the 
consumers. For the other Classes (II and III) there are no regulations for how consumers have to 
be alerted. FDA requires only drug companies to have a plan for each type of recall.  
 Most of the patient safety issues regarding the outdate management process are within the 
scope of inventory management practices including periodic search in inventory locations and 
outdated product identification. Disposal is also an important issue because of the impact of toxic 
materials to the environment as well as the disposed amount. It is estimated that healthcare 
facilities waste 250 million lbs. of drugs a year (Donn et al., 2008). Outdate management 
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processes are typically continuous processes that are embedded into the general supply chain 
operations. Some of the best practices for better outdate management include: 
 New products (stock) should be placed in back of the older ones 
 All products that have an expiration date should have a clear label 
 Every three months, there should be an expiration date check and based on the findings label 
the products close to expiration date with color codes. 
 Check for the products that are not being used frequently and relocate them to other units if it 
is possible. 
According to the U.S. Environmental Protection Agency (EPA, 2008), waste 
minimization and reverse distribution systems, used in California, Minnesota, and Washington, 
are some of the good practices identified to date. Waste minimization techniques include 
identifying the products that are close to expiration and maintaining inventories of highly used 
products, redistributing and sending them to other places where they are needed and can be used. 
Focusing on pharmacy products, Joint Commission Resources Inc. suggests each pharmacy to 
have and apply a system in order to avoid expired products from remaining in stock. Such a 
system should contain effective methods to find and dispose outdated, deteriorated, recalled or 
obsolete drugs and supplies. Products that are going to expire in the next 60 to 90 days should 
have tags to alert staff to select these products first and use them only if administration will be 
completed before the expiration date (Joint Commission Resources Inc., 2001).  
Inventory accuracy is one of the key performance measures that monitor inventory 
transactions on a continuous basis. It is also an adding factor to patient safety in healthcare. The 
errors in the inventory records can lead to problems such as insufficient replenishment decisions 
and high operational costs. The greatest concern in managing inventory is ensuring the right 
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product is available at the right time. In other words maximizing product availability at the POC 
(never run out of product) and minimize adverse medical consequences in the event that product 
is not available (Opolon, 2010). 
The complex nature of healthcare supply chains has increased the need of sharing 
accurate and timely information of products and partners. Increasing costs and disjointed product 
and partner/location information in the healthcare supply chains strengthen the need for having 
effective and operative supply chain management practices. The cost of supplies constitutes the 
second largest expense for healthcare providers (ASU, 2010). Several decades ago, other 
industries, including retail, grocery, and automotive, employed advanced standardized product 
and partner identifier technologies and started taking advantage of them. A study estimated that 
the adoption of Universal Product Code (UPC) helped retail industry save $17 Billion in 1999 
(Jayaraman et al., 2011). However, healthcare industry is moving at a slow pace. As reported by 
Simpson and Kleinberg (2009) the main contributors for the slow adoption include market 
drivers and technology issues. 
Standardized product and partner identifier technologies in the healthcare supply chain 
are essential for effective information exchange through the supply chain. Existence of global 
standards for identification, especially when coupled with automatic identification technologies, 
help to track individual healthcare product (drugs, devices, biologics and blood products) to 
ensure safety and efficiency. Reduced human errors by enabling automatic data capture reduce 
ambiguity when identifying products (Zirkle et al., 2012). For drugs, correct identification 
assures the right product in the right dose reaches the right patient at the right time through the 
right route (the “five patient rights”). For devices, the five patient rights become eight patient 
rights: the right patient, the right device, the right location, the right time, the right condition, the 
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right procedure, the right anatomic site, and the right user (healthcare professional). Standard 
product identifiers also assist to track back the history of products as they move through the 
healthcare supply chain (Bix et al., 2007) and provide increased recalled product management 
and improved service quality. As a result, data standards contribute to increase patient safety.  
Currently the adoption of data standards is not prevalent and there is no agreement among 
the stakeholders in the healthcare supply chain on the identification standards (product and 
location) that can be used by all of them. The use of stakeholder specific identification numbers 
is more common and cause to confusion, supply chain process inefficiency, and lack of visibility 
to track the product flow (Jayaraman et al., 2011). In addition to the patient safety, the benefits of 
standardized product and partner/location identifier technologies in the healthcare supply chain 
can be summarized as follows: 
 Streamlined inventory management by reducing process errors and redundancies 
 Increased visibility into the supply chain and improved decision support with consistent and 
accurate data (Zirkle et al., 2012) 
 Enabled automatic data recording and ensured information quality 
 Increased inventory accuracy  
 Time savings in product preparing, shipping and receiving 
 Efficient order replenishment 
 Better and faster inventory management and better monitoring products on the shelves 
 Proactive staffs who spend less time trying to obtain data and more time analyzing 
information to make decisions  
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Recall and Outdate Management at Providers 
In order to investigate the impacts of standard product and partner/location identifying 
data on inventory accuracy, and recall and outdate management policies, a set of processes was 
identified. The process flow was developed and validated in collaboration with six different 
healthcare providers. The flow is illustrated in Figure 2. These processes are the 
conceptualization of the product and information flow for the recall and outdate management 
policies from the healthcare provider perspective. The figure contains 3 main parts. As 
illustrated, the first set of processes, referred as Part 1, is related to outdate management and 
includes the continuous monitoring of outdated products during standard supply chain operations 
and internal replenishment processes (box 1) as well as the capturing, storing and retrieving 
expiration date data for products (box 3). For example, the expiration dates of products can be 
validated at receiving or while replenishing nursing units. Also, expiration dates of products can 
be stored in the Materials Management Information Systems (MMIS) in order to trigger alerts 
when product is close to expiration date. 
The second set of processes, referred as Part 2, is related to the recall management and 
includes the processes triggered by the recall notification until the case is considered closed (box 
4). These processes include identifying and notifying provider units that potentially receive the 
recalled products as well as retrieving, disposing and/or returning. After receiving the 
notification or alert, materials management at a provider start checking the purchasing history to 
see whether the recalled product has been purchased or not. If the product was purchased the 
implicated areas are notified; otherwise the recall case is closed. For the implicated units, the 
recalled products are identified and retrieved from the storage locations by the materials 
management and nursing staff to be disposed. In addition, if a recalled product was administered 
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to a patient, another set of process including patient identification and notification takes place. 
Capturing, storing, and tracking the recalled product lot number and other related information for 
recalled products are also required in this set of processes (box 3).  
The third set of processes, referred as Part 3 in the figure, is related to the product 
administration at POC; this is the last point to validate correct product (e.g. correct size, correct 
dose), correct patient, correct time as well as to identify expired or recalled products before 
administration. Clinical personnel perform product and patient validation activities in order to 
maximize patient safety. 
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Figure 2: Recall and Outdate management processes 
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CHAPTER 3 
METHODOLOGY 
3.1. SYSTEM OVERVIEW 
A simulation model is used to model a typical healthcare provider (i.e. hospital) supply 
chain operations and internal replenishment processes. The system under study covers the supply 
chain starting from the bedside administration through to the supplier warehouse and 
manufacturer. The model simulates the product and information flow and considers different 
location points in the supply chain operations including POC to validate the products for 
inventory management and accuracy as well as their expiration dates for outdate management, 
and lot and serial numbers for recall management. In order to measure the impacts of standard 
product and partner/location identification (GS1 Data Standards), common process errors are 
added to the system which are used to quantify the probabilities of identifying the products 
incorrectly, or missing a recalled or outdated product during the validation processes. 
The simulation model considers two types of generic medical/surgical (med/surg) 
products and their PAR locations (i.e. inventory or utility rooms for medical products) as the last 
inventory holding point at the hospital. In addition, there is one central store (CS) at the hospital 
where the products are stored in bulk. A warehouse (WH), which supplies products to the 
hospital, and a manufacturer (MFG), which is the unlimited source of products, are also 
simulated in the model. 
When a demand for either type of products occurs based on patient arrival for treatment, 
the inventory at the PAR location is checked. In case of enough on-hand product inventory, the 
demand is fulfilled, on-hand inventory level is reduced by the patient’s demand, and the patient 
leaves. Otherwise, the product is backordered to CS and the patient waits until the demand is 
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fulfilled. In this case, an emergency order is sent to CS for only the demanded amount of 
products. In addition to these emergency orders, PAR locations are replenished daily. They 
operate under an “order-up-to” inventory management policy, where PAR location shelf capacity 
minus on-hand inventory is ordered every day for each product type. During the daily 
replenishment process, inventory positions (i.e. on-hand inventory + on-order inventory) are 
checked. If the inventory positions for products fall below the shelf capacity, the system orders 
enough amounts of individual products to reach the capacity.  
CS operates under a continuous review inventory policy, where inventory position is 
monitored continuously after every time an order is sent. Products are received in boxes at CS 
and each product is separated before PAR replenishment. On-order inventory (and inventory 
position) is updated when receiving an order from WH and on-hand inventory (and inventory 
position) is updated when sending an order to PAR. When the inventory position of a product 
goes below its reorder point at CS, a box full of products are reordered and on-order inventory is 
updated. If on-hand inventory at CS is insufficient to fulfill a daily PAR order, then all on-hand 
inventory is sent to the PAR, the inventory levels are updated, and one box of products are 
backordered to WH. Since inventory position is monitored continuously after every time an order 
is sent, a CS replenishment order may be generated based on the inventory position. If on-hand 
inventory at CS is insufficient to fulfill an emergency PAR order, then all on-hand inventory is 
sent to the PAR and same as the case with insufficient inventory to fulfill a daily PAR order, one 
box of products are backordered to WH, and the inventory levels are updated.  
WH operates under a similar inventory policy. Products are received on pallets at WH 
and each box is separated before CS replenishment. On-order inventory is updated when 
receiving an order from MFG and on-hand inventory is updated when sending an order to CS. 
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When the inventory position of a product goes below its reorder point at WH, a pallet full of 
products are reordered and the inventory position is updated. If on-hand inventory at WH is 
insufficient to fulfill a regular CS order, then all on-hand inventory is sent and the inventory 
position is updated. Inventory flow of the model is depicted in Figure 3. 
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Figure 3: Inventory Flow of the Model 
 18 
 
 A number of potential validation points are identified in a provider supply chain system 
where the continuous product monitoring occurs before or after product transactions. Products 
and/or patients are identified and validated at these points to make sure that right (correct type) 
and safe (not recalled and not outdated) products are used for right patients. These validation 
points include: 
1. Bedside: A validation process before administering products to patients.  
2. PAR Picking: A validation process while picking the products from the PAR locations 
before using them.  
3. PAR Receiving: A validation process while receiving products from central storage. 
4. Central Storage Picking: A validation process while picking the products at the central 
storage to replenish PAR locations. 
5. Central Storage Receiving: A checking process while receiving products from the 
warehouse. 
6. Warehouse Picking: A checking process while picking the products to replenish central 
storage. 
7. Warehouse Receiving: A checking process while receiving products from the 
manufacturer. 
Product types, expiration of them, and lot number (for recall purposes) may be checked at 
these potential validation points. Note that the number of products to be validated, the amount of 
validation time as well as validation procedure may change at each point. It may not be feasible 
or practical to utilize validation process at every point in the supply chain; thus, validation 
process may take place at only a few of these potential points in the hospital.  
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In addition to the validation points in the supply chain, possible errors that may occur during 
these processes, are simulated in the model such as misidentifying products, missing expired, or 
recalled products. Using data standards help improve the validation processes and reduce these 
errors. Furthermore a number of inventory management related errors are simulated in the model 
including stock-loss (shrinkage) errors, transaction errors, ordering errors (misordering), and 
errors during replenishment (misplacement and mispicking).  
Stock-loss errors occur when on hand inventory decreases due to some unpredicted 
events such as theft or personnel mistakes. Stock-loss errors occur at warehouse, central storage, 
and PAR levels. Transaction errors happen when products are transported from the supplier to 
the warehouse, from warehouse to central storage, and also from central storage to PAR. These 
errors can affect replenishment decisions, like reorder point and reorder quantity. Ordering errors 
happen when replenishment demand is generated and it is either wrong amount ordered or wrong 
product ordered. Misordering happens while demand is generated for PAR, central storage, and 
warehouse.  Misplacements and mispickings also happen while putting products in wrong 
shelves or taking them from wrong shelves. Validation related and inventory management 
related errors and their modeling details will be explained in the next section.  
 
3.2. SYSTEM MODEL 
 Assumptions 
 Following assumptions are used in the model: 
1. The time between arrivals of patient follows an exponential distribution. 
2. System includes two types of products. 
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3. Since there are two types of product in the system, the entire inventory holding areas contains 
two shelves for each type. 
4. Each patient requires only one type of products, either type one or type two.  
5. Each patient requires 1, 2, 3, 4, or 5 products of a same type. The probability of amount 
demanded is equal and follows a discrete distribution.  
6. Manufacturer is assumed as an infinite source of product, so it can fulfill the demand 
whenever it is required.  
7. The reorder point and the reorder quantity for warehouse shelves are 10 boxes and 1 pallet 
(including 10 boxes respectively).  
8. The reorder point and the reorder quantity for central storage shelves are 100 and 100 
products respectively.  
9. PAR bins capacities are 50 products.  
10. Areas for validation are: warehouse receiving, warehouse picking, central storage receiving, 
central storage picking, PAR receiving, Par picking, and bedside administration. 
11. Expiration date for products follow a normal distribution and the manufacturer do not send 
expired products to the hospital. 
12. Recall notification arrivals follow an exponential distribution.  
13. Stock-loss error occurs based on exponential distribution. 
14. Cart count at PAR location occurs every day and corrects the recorded inventory and 
misplacements only if the actual on hand inventory is more than twice of recorded inventory 
or the actual on hand inventory is less than half of recorded inventory. 
15. Cycle count in central storage happens every year to correct the recorded inventory and 
misplacements. It is an immediate action. 
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16. Cycle count in warehouse happens every year to correct the recorded inventory and 
misplacements. It is an immediate action. 
The time between patient arrivals is assumed to follow an exponential distribution, so the 
demand process is a Poisson distribution. Two types of products are simulated in the model with 
the same demand probability. The probability of demand associated with each type has discrete 
distribution. Upon the customer arrival, product demand type and amount are determined in the 
model. A discrete distribution is used for the amount of demand and with equal probability the 
patient demand amount can be 1, 2, 3, 4, or 5.  
In addition to patient demand, there is also another demand for replenishment. 
Replenishment demand for PARs is generated after every cart count (occurs every day) and is 
sent to the central storage. Replenishment demand amount is the difference between the 
maximum capacity of PAR bins and numbers of products in the bins.  
Replenishment demand for central storage and warehouse also can be generated after 
each replenishing process when the system checks the inventory position of CS and WH. If 
inventory position of CS or WH is less than reorder point, replenishment demand is generated 
and asks for certain amount of products. 
Transportation 
 The system under study has different locations that hold products. Manufacturer where 
products are created and warehouse are out site locations, central storage and PAR levels are 
within the hospital locations. So, transportation activities take place between these areas and they 
are modeled as determined delays. There are costs associated with transportation between 
manufacturer and WH and transportation between WH and CS since they are out site hospital 
locations. 
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 Once the order sends to the WH or CS, WH or CS checks the on hand inventory in order 
to satisfy the demand. When the order is ready and sent, it takes a certain amount of time to 
reach to the next location. When the next location receives the order, the inventory records are 
updated. 
Stock-loss error 
 As it mentioned before, stock-loss is the unrecorded loss of inventory because of 
unexpected events. When the stock-loss error occurs, one unit of products will be deleted from 
the system without the inventory records are updated (unit of products at WH is boxes that 
contains 100 products, so as the stock-loss error happens 100 products are deleted at once at WH, 
unit of products at CS and PAR is individual products so as the stock-loss error happens one 
product is deleted). 
Stock Loss Error 
Event Occurs
Shelf Empty?
WaarehousePARWH/ CS/ PAR
End Logic
Decrement 
Actual on hand 
inventory by 
error amount
No
Yes
 
Figure 4: Stock-Loss Error 
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The implementation of stock-loss error into the model is demonstrated in Figure 4. The 
time intervals between the stock-loss errors are based on exponential distribution, but the 
frequency of occurrence is different in different locations (WH, CS, and PAR). Since there are 
two types of products in the systems, stock-loss error affects the shelf related to only one of the 
product’s type each time it occurs. When stock-loss error occurs the actual inventory on hand 
inventory is checked and if the value is not zero, then the actual on hand inventory decreased by 
one.  
Transaction error 
  When the replenishment order is received, there is a probability of making transaction 
error which is defined by a variable and we can set it to a certain value. Same thing can happen 
while picking products from shelves. Since two types of product are in the system, we have two 
types of transaction errors. First, is receiving or picking either one of the products while updating 
the records for the other product. Second, is updating the wrong amount in the record and the 
wrong amount can be positive for receiving and negative for picking process. Therefore, when 
either of these errors happens system updated the recorded inventory and inventory position 
incorrectly. The wrong amount can be plus or minus 1, 2, or 3 which is followed a discrete 
distribution. The implementation of transaction error into the model is illustrated in Figure 5.  
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Figure 5: Transaction Error 
Misordering 
 In order to replenish the inventory in different locations (Warehouse, Central storage, and 
PARs), inventories are checked based on the policy of the location (WH and CS perform under 
(s, S) policy and PARs follow order up to policy). When the replenishment is required, demand 
is generated and system places an order. There is a possibility of error while ordering. Two types 
of errors can occur. Ordering wrong amount which can be positive or negative (in negative case 
if the demand value becomes zero or less, no order is placed). As an example, when 40 products 
are needed to replenish PAR, system orders 43 or 38. Ordering wrong product which is ordering 
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product type two instead of type one and vice versa. In addition to that there is a possibility that 
the errors happen at the same time since they are independent.  
Misplacing and mispicking 
 In addition to the errors mentioned is previous sections, there is also misplacing and 
miss-picking errors that can occur during the inventory management processes. Since the model 
includes two types of products and shelves for stocking them, misplacement can happen by 
putting product type one into the shelves related to product type two and vice versa, while miss-
picking can happen by picking from a wrong shelf. So, when these errors occur, they messes up 
the whole inventory records. For example, when type one products are put in shelves for type 
two products, or when type one products should be picked and type two products are picked, the 
inventory information of the products changes incorrectly. Misplacement is embedded to the 
system while sending the products. Probability of having misplacement errors is defined by 
variables that can be set before running the model and with that probability, products are sent to 
wrong shelves. Probability of having miss-picking errors is also defined by variables that can be 
set before running the model and with that probability products are picked from wrong shelves. 
Cycle counting 
 Cycle counting is usually used to improve the inventory accuracy. It is common that 
during the cycle counting the system is shut down to make sure the items are not moving and 
every one of them is counted. Because of the complexity of the system, it is assumed that cycle 
counting happens immediately in the model. Cycle count events happen in CS and WH and 
correct the misplacement errors as well as records. During each cycle count, “product type” of all 
products is checked to ensure they are in right place and if not, they will be moved to the correct 
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location. After correcting the misplacement errors, the recorded inventory is reset to the actual on 
hand inventory value. The logic of cycle count is shown in Figure 6.  
Cycle counting is done to reduce the number of stock-loss that might happen in the 
system. After correcting the records, the inventory position is also checked to determine if the 
replenishment order needs to be sent or not. 
Cycle count at 
WH/CS
Search for 
misplacements
Remove them 
and put them in 
correct location
Correct the 
records
Need 
replenishmen
t?
Order
End logic
Found
Not found
Yes
No
 
Figure 6: Cycle Counting  
 
Cart counting 
 Other than cycle counting, which is used in warehouse and central storage to correct 
misplacements and records, there is a cart counting event in PARs. Since PAR locations are not 
 27 
 
big like WH and CS, and also it is closest inventory place to the patients, cart counting occurs on 
daily bases to correct misplacements, correct records, avoid stock-losses, and ensure enough 
products are available for patients.  
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Figure 7: Cart Counting 
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As mentioned before, PARs are following an “order up to” policy. So, whenever cart 
counting occurs, the difference between the PAR capacity and PAR inventory position is 
ordered. But the purpose of cart counting is not only ordering, therefore misplacement and record 
corrections are also embedded in the system and triggered when the difference between actual on 
hand inventory and recorded inventory at PARs reaches a certain amount. The idea of cart 
counting can be seen in Figure 7. 
Recall process 
 The Model generates recall notifications based on exponential distribution. Whenever 
there is a recall, the recall lot (which is randomly chosen from zero and maximum value of 
products lot number) and recall type (which is either one or two) added to a list (list of recalls). 
List of recalls are considered so there is a chance to catch recalled products which are missed in 
previous recall validations due to the errors. 
When recall is notification received, the system searches all the inventory locations. System 
checks recall lot and recall type value against lot number and type of the products and when it 
matches, the products will be removed from the shelves. This process continues untill all the 
products are checked against all the recall notifications in the list.  
Validation  
 Other than the inventory related errors discussed before, there are errors related to 
validation. Seven locations can be used to validate three issues. The locations are: warehouse 
while receiving products from the manufacturer, at warehouse while picking the products to 
replenish central storage, central storage while receiving products from the warehouse, at central 
storage while picking the products to replenish PAR locations, while picking from the PAR 
locations to be used, and the last validation point is before administering it to a patient (bedside). 
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The issues to be checked are: Expiration date, recall check, and identification (if the product is 
right). It is done to prevent inappropriate products from being used for patients. 
In the simulated system, every product has an expiration date, lot number, and type 
number (either 1 or 2). These are assigned as soon as they are produced at the manufacturer. 
Expiration date, lot number validations, and product identification can be done at different points 
of the supply chain and there are errors associated with these validation processes. Therefore, 
different scenarios are created based on validation points to see which ones produce better results 
based on the number of recalled, outdated, or misidentified products given to a patient. Binary 
variables are used associated to each validation point in the model so when they are set as one it 
means that product will be checked there otherwise there is no check at that location. The 
validation process is depicted in Figure 8. 
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Figure 8: Validation Process 
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3.3. MODEL INPUT 
Table 2 summarizes all the input in the model. Some of the inputs given below are based 
on the location and might vary in different locations (it is demonstrated in the table). Different 
locations are warehouse receiving, warehouse picking, central storage receiving, central storage 
picking, PAR receiving, PAR picking and bedside. 
Table 2: Model inputs 
 
Outdate check  
 
WH, CS, PAR, BS 
 
Binary 
 
Recall check  
Identification check 
WH, CS, PAR, BS 
WH, CS, PAR, BS 
Binary 
Binary 
 
Outdate mgmt. error rate   WH, CS, PAR, BS %  
Recall mgmt. error rate  
Misplacement error rate  
Mispicking error rate 
WH, CS, PAR, BS 
WH, CS, PAR, BS 
WH, CS, PAR, BS 
% 
% 
% 
 
Reorder quantity WH Boxes  
Reorder point  
Reorder quantity  
Reorder point  
Reorder point  
WH 
CS 
CS 
PAR 
Boxes 
Units 
Units 
Units 
 
Capacity PAR Units  
Time between patient arrival 
Time between stockloss 
Stockloss amount 
 Hours 
Days 
Units 
 
Product expiration time  Minutes  
    
 
Some of the inputs varied within the experimental design while others are kept the same 
in order to find the effect of the factors of interest. A detailed explanation of which inputs are 
changed and why they are changed is given in the result section. 
3.4. PERFORMANCE MEASURES 
 31 
 
Recall that the system under study tries to find the impact of GS1 standards on patient 
risk and supply chain. Therefore, the system performance measures are grouped in two 
categories: 
1) Risk analysis: In order to investigate the impact of GS1 on risk four different settings 
are studied. First, the system includes errors in supply chain processes such as 
ordering receiving, putting away or replenishing and also errors in checking processes 
such as check for outdates, recalls, and misidentified products. Second, the system 
that has errors in supply chain processes but no checking errors. This means that 
checking processes are automated and are using GS1 but there are errors in supply 
chain processes. Third, system with only errors in checking processes. This means 
that GS1 has been implemented and used in supply chain processes (processes has 
been doing automatically) that there is no error in them. Last one is the system with 
no error in either of the supply chain and checking processes. In all these four settings 
the performance measures are as follow: 
a. Number of unsafe products (misidentified-incorrect, outdated or recalled 
products) that are registered to patients. 
b. Patient’s demand waiting time which is the delay of providing care 
2) System performance analysis: Following performance measures are used to explore 
if the system can be more efficient by reducing the cost of holding inventory and 
number of transportation as well as more precise records.   
a. Inventory descrepency which is the difference between actual and recorded 
inventory 
b. Average inventory that shows the mean level of inventory in different locations 
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c. Number of transportation that occurs between different locations for replenishing  
 
 
CHAPTER 4 
RESULTS AND CONCLUSION 
The simulation experimentation was performed for different scenarios and the 
performance measures introduced in previous section were explored. In addition, cost 
effectiveness analysis has been done to find the best scenarios based on different cost and risk 
factors.  
4.1. RESULT SUMMARY 
The developed model is run for 10 replications for each scenario. Each replication length 
is 1000 days and the warm up period is 90 days before the system results are collected. Two 
types of products are considered in the model to have the ability of simulating the 
misidentification. These products have the expiration date of 180 days. Patients’ arrival time in 
the model is based on a Poisson process with a rate of one every 3 hours and recall notifications 
are received every 7 days. 
Twenty two scenarios were performed based on the 7 different locations to validate 
products and performance measures were observed. However, there were 128 possible scenarios 
(2
7
,
 
since in each location there is an option to validate products or not), 22 of those were 
considered due to the high possibility of getting similar results for validating at locations where 
products’ flow happen in short period of time. Therefore, locations warehouse picking and 
central storage receiving, central storage picking and PAR receiving, PAR picking and bedside 
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were both either considered as validation point or not at the same time. Table 3 demonstrates the 
scenarios. 
 
 
 
Table 3: Model scenarios 
1 No check 
wh = warehouse 
cs= central storage 
bs = bedside               
r = receiving               
p = picking 
2 wh r 
3 wh p 
4 cs r 
5 cs p 
6 par r 
7 par p 
8 bs 
9 wh p, cs r 
10 cs p, par r 
11 par p, bs 
12 wh r, wh p, cs r 
13 wh r, cs p, par r 
14 wh r, par p, bs 
15 wh p, cs r, cs p, par r 
16 wh p, cs r, par p, bs 
17 cs p, par r, par p, bs 
18 wh r, wh p, cs r, cs p, par r 
19 wh r, wh p, cs r, par p, bs 
20 wh r, cs p, par r, par p, bs  
21 wh p, cs r, cs p, par r, par p, bs 
22 all checks 
 
Recall that, in order to do risk analysis and find out the impact of GS1, four systems were 
examined. The systems with: 
1. Supply chain processes error and checking processes error 
2. Supply chain processes error but no checking processes error 
3. No supply chain processes error but checking processes error 
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4. No supply chain processes error and no checking processes error 
Tables 4, 5, 6, and 7 include 22 scenarios with three performance measures related to 
unsafe products that are administered to the patients for each one of the systems. 
The system which has supply chain process error and checking process error, is more like 
what exists in reality. In this case, as it is expected, the model shows that when the validation 
process is closer to the point of care/bedside (where the products are administered to the patients) 
the number of unsafe products used for a patient is smaller. However, when the number of 
validation points increases, it does not necessarily mean that the number of unsafe products 
administered to the patients will be reduced. Considering these three performance measures 
indicate that scenario with only checking at bedside is good enough to avoid using unsafe 
product for patients but considering other performance measures might impact it. 
Table 4: Supply chain error - Check error 
Supply chain error - Check error 
Scenario Misidentified Outdated Recalled 
1 2070.3 2642.6 760.8 
2 1663.3 1856.9 434.5 
3 1567.7 831.6 365.8 
4 489.9 516.4 191.3 
5 201.7 250.3 86.6 
6 35.8 81.2 9.8 
7 32.4 52.6 5.9 
8 5.2 8.3 1 
9 481.9 519.1 177.7 
10 30.8 55.6 7.3 
11 7.2 7 1.4 
12 453.7 491.2 165 
13 28.9 49.6 2.6 
14 3.2 4.5 0.5 
15 17.3 14.5 5.8 
16 2.3 1.4 0.8 
17 1.7 1.7 0.9 
18 9.9 9.9 4.3 
19 1.4 1.6 0.4 
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20 0.6 0.3 0.1 
21 0.3 0.2 0.4 
22 0.1 0.2 0 
 
 
 
The graphic view of the output is also illustrated in the following figure. 
 
Figure 9: Number of recalled, outdated, and misidentified products for Supply chain error - 
Check error system 
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The system with supply chain processes error but no checking processes error is when 
GS1 implementation is used for checking processes. It is assumed that the checking processes 
are done automatically using GS1 (e.g. if a product is recalled, by scanning the barcode some 
warning will appear on the screen). The results for this system also follow the same pattern as the 
previous system but overall the output values for that are smaller due to the implementation of 
the GS1. 
Table 5: Supply chain error - No check error 
Supply chain error - No check error 
Scenario Misidentified Outdated Recalled 
1 2024.2 2439.6 715.6 
2 1847.4 1925.4 514.9 
3 1297.5 801.7 186.6 
4 329.1 407.6 55.1 
5 96.5 118.3 37.3 
6 20.9 23.2 1.6 
7 0 0 0 
8 0 0 0 
9 284.1 407.9 37.2 
10 18.6 20.7 1.2 
11 0 0 0 
12 256.4 351.8 19.4 
13 18.8 20.9 1.3 
14 0 0 0 
15 11.6 17.1 0.8 
16 0 0 0 
17 0 0 0 
18 9.3 15.4 0.8 
19 0 0 0 
20 0 0 0 
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21 0 0 0 
22 0 0 0 
 
 
Figure 10: Number of recalled, outdated, and misidentified products for Supply chain error - 
No check error system 
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The system with no supply chain error but check error is when supply chain processes are 
free of errors. This is because of the perfect supply chain processes due to implementing of GS1 
and automation. Therefore, there is no misplacement and mispicking in replenishing, no errors in 
ordering, and no misses in recall management. As a result, there is no misidentified and recalled 
product administered to the patients. There is still a chance of using outdated products for 
patients based on the location of the validation point. 
Table 6: No supply chain error - check error 
No supply chain error - check error 
Scenario Misidentified Outdated Recalled 
1 0 2382.2 0 
2 0 1922 0 
3 0 800.9 0 
4 0 501.6 0 
5 0 234.9 0 
6 0 73.8 0 
7 0 52.4 0 
8 0 9.4 0 
9 0 565.2 0 
10 0 48.1 0 
11 0 8.1 0 
12 0 506.5 0 
13 0 49 0 
14 0 4.2 0 
15 0 15.4 0 
16 0 1.9 0 
17 0 2 0 
18 0 8.8 0 
19 0 2.1 0 
20 0 0.4 0 
21 0 0 0 
22 0 0 0 
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Figure 11: Number of recalled, outdated, and misidentified products for No supply chain 
error - check error system 
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This system is the ideal case where there is no error in supply chain and checking 
processes. So it has the advantages of the two previous cases (no misidentified and recalled 
products are used for patients as well as mostly smaller values for outdates).  
Table 7: No supply chain error - No check error 
No supply chain error - No check error 
Scenario Misidentified Outdated Recalled 
1 0 2137.2 0 
2 0 1953.6 0 
3 0 948.2 0 
4 0 418.7 0 
5 0 90.1 0 
6 0 18.4 0 
7 0 0 0 
8 0 0 0 
9 0 372 0 
10 0 15.6 0 
11 0 0 0 
12 0 343.9 0 
13 0 21.8 0 
14 0 0 0 
15 0 18.6 0 
16 0 0 0 
17 0 0 0 
18 0 15 0 
19 0 0 0 
20 0 0 0 
21 0 0 0 
22 0 0 0 
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Figure 12: Number of recalled, outdated, and misidentified products for No supply chain 
error - No check error system 
 
In order to evaluate how to enable the validation points effectively and efficiently, the 
most realistic system (system with supply chain and checking processes error) was examined. 
Performance measures that were investigated are average waiting time of a patient’s demand to 
receive products, total time of checking processes per receiving/replenishing, total average 
inventory in all inventory locations, total inventory discrepancy in all locations, and total number 
of shipments in 1000 days. The detailed table of each performance measure and graphic view of 
them are provided. 
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Table 8 and 9 shows the average waiting time of a patient’s demand and time spent on 
checking in each scenario. Checking the Figure 13 indicates that central storage picking and 
PAR receiving checking processes have the most impact on the patient waiting time. It is 
probably because the amount of products that must be validated in these processes, therefore, it 
might delay the service. Bars associated with time of checking in scenarios including central 
storage picking and PAR receiving checks also admits that.  
Table 8: Average waiting time of a patient’s demand 
supply chain error & check error 
waiting time 
(min) 
1 No check 0.32 
2 wh r 1.23 
3 wh p 1.18 
4 cs r 1.42 
5 cs p 4.01 
6 par r 3.19 
7 par p 2.09 
8 bs 1.1 
9 wh p, cs r 2.2 
10 cs p, par r 5.54 
11 par p, bs 2.18 
12 wh r, wh p, cs r 1.51 
13 wh r, cs p, par r 3.02 
14 wh r, par p, bs 1.93 
15 wh p, cs r, cs p, par r 4.81 
16 wh p, cs r, par p, bs 2.33 
17 cs p, par r, par p, bs 5.72 
18 wh r, wh p, cs r, cs p, par r 5.18 
19 wh r, wh p, cs r, par p, bs 2.6 
20 wh r, cs p, par r, par p, bs  4.4 
21 wh p, cs r, cs p, par r, par p, bs 4.91 
22 all checks 5.37 
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Table 9: Time spent on checking 
time to check (min) 
Scenarios wh cs par bs total 
1 0 0 0 0 0 
2 2.4 0 0 0 2.4 
3 0.17 0 0 0 0.17 
4 0 13.3 0 0 13.3 
5 0 8.24 0 0 8.24 
6 0 0 4.19 0 4.19 
7 0 0 0.27 0 0.27 
8 0 0 0 0.26 0.26 
9 0.2 9.25 0 0 9.45 
10 0 9.1 4.88 0 13.98 
11 0 0 0.33 0.22 0.55 
12 2.7 12.4 0 0 15.1 
13 2.42 7.8 4.3 0 14.52 
14 2.55 0 0.24 0.17 2.96 
15 0.18 23.12 4.7 0 28 
16 0.16 13.81 0.22 0.2 14.39 
17 0 7.9 4.4 0.3 12.6 
18 2.63 21.11 4.34 0 28.08 
19 2.14 12.57 0.3 0.21 15.22 
20 2 8.66 4.5 0.22 15.38 
21 0.28 23.77 4.22 0.19 28.46 
22 2.5 24.04 4.29 0.26 31.09 
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Figure 13: Waiting time and time spent on checking 
So far, considering the previous performance measures indicates that validating the 
products closer to the point of care is the best. It is true that checking at very last validation 
locations leads to have small values for number of unsafe products administered to the patients, 
shorter amount of time spent on checking, and shorter waiting time for patients’ demand. But it 
can lead to keep the undesired products (outdated/recalled) on the shelves longer, therefore, 
increase the inventory holding cost and can increase the risk of running out of products when 
there is a higher demand in the system.  
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Table 10 and figure 14 indicate that validating at warehouse can help to reduce overall 
inventory level. Since warehouse deals with boxes of products (100 products in each box) 
eliminating the undesired products from staying on the shelves early in the system might be the 
reason to lower the inventory level. 
Table 10: Average inventory 
average inventory 
Scenarios wh (box of 100 products) cs (units) par (units) total (units) 
1 12 154 35 1389 
2 11 144 39 1283 
3 11 141 33 1274 
4 12 123 33 1356 
5 12 129 30 1359 
6 12 137 24 1361 
7 12 133 28 1361 
8 12 132 29 1361 
9 11 117 36 1253 
10 12 126 23 1349 
11 12 136 22 1358 
12 11 119 36 1255 
13 11 124 27 1251 
14 11 130 28 1258 
15 12 116 26 1342 
16 11 125 28 1253 
17 12 124 21 1345 
18 11 116 25 1241 
19 11 121 20 1241 
20 11 124 20 1244 
21 11 116 19 1235 
22 11 116 20 1236 
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Figure 14: Average inventory 
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Inventory discrepancy is defined as the difference between the actual on hand inventory 
and the recorded inventory. During supply chain processes such as receiving and replenishing, 
there is a possibility of putting products in wrong shelves, picking from wrong shelves, or losing 
products, therefore, the inventory records will become inaccurate. Results from the scenarios 
indicate that when validation at warehouse picking occurs the overall inventory discrepancy is 
smaller than other cases. During the validation, misidentified products will be found and put 
back to their correct place and records will be updated, so warehouse picking that deals with 
large amount of products would be an important place for validation to have better and more 
accurate inventory. 
Table 11: Inventory discrepancy 
inventory discrepancy 
Scenarios wh (boxes) cs (units)  par (units) total (units) 
1 1.2 17 4 141 
2 1 18 4 122 
3 0.4 15 5 60 
4 1 9 4 113 
5 1.1 11 4 125 
6 1 15 2 117 
7 1 16 0 116 
8 1.1 16 0 126 
9 0.4 9 4 53 
10 1 8 2 110 
11 1.1 17 0 127 
12 0.9 10 4 104 
13 0.9 10 3 103 
14 1 20 0 120 
15 0.4 7 2 49 
16 0.5 9 0 59 
17 1 10 0 110 
18 0.9 7 2 99 
19 0.8 11 0 91 
20 1 10 0 110 
21 0.5 7 0 57 
22 0.3 8 0 38 
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Figure 15: Inventory discrepancy 
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The number of replenishment is the performance measure to measure the cost of 
transportation from manufacturer to the warehouse and from warehouse to the central storage. In 
addition it is used for the cost of FTE (full time employee) to transport (replenish) the PARs 
from central storage. Figure 16 demonstrates the total number of transportation between the 
locations through 1000 days and actually there is no obvious trend. 
Table 12: Number of replenishment 
# of replenishment 
Scenarios mfg to wh wh to cs cs to par total 
1 17 134 943 1094 
2 19 145 953 1117 
3 17 147 958 1122 
4 16 159 949 1124 
5 16 151 950 1117 
6 17 140 971 1128 
7 16 138 964 1118 
8 16 136 962 1114 
9 17 150 944 1111 
10 17 156 967 1140 
11 18 141 939 1098 
12 16 148 946 1110 
13 16 152 951 1119 
14 17 150 955 1122 
15 17 158 949 1124 
16 15 157 950 1122 
17 16 161 939 1116 
18 16 164 960 1140 
19 17 158 948 1123 
20 17 161 947 1125 
21 17 169 957 1143 
22 18 173 941 1132 
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Figure 16: Number of replenishment 
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4.2. COST-EFFECTIVENESS ANALYSIS 
In this section cost-effectiveness analysis of performance measure will be discussed. In 
order to do cost-effectiveness analysis, “precision tree” tool (one of the Add-Ins in Excel) has 
been used.  Performance measures set to a default value as an indicator of cost or risk (like $5 
cost for every minute of validation or $5 for correction of the inventory record, 5% risk to the 
patient’s health due to administration of unsafe product or 5% risk to health of a patient for every 
minute delay of service). Risk related performance measures (number of unsafe products 
administered to patients and waiting time of the patients’ demand) and supply chain related 
performance measures (time to check, average inventory, inventory discrepancy, and number of 
replenishment) considered separately. Total expected value of risk related performance measures 
and supply chain related performance measures are used to analyze each performance measure 
(sum of performance measures multiply by cost or risk factor). Therefore, the default value of 
each performance measure has been changed in the range of (0, 30) and multiplied by the values 
of the performance measure in each scenario. The results are shown in following figures and 
discussed.  
Figure 17 represents different scenarios and how the expected value of performance 
measure “time of checking” varies with the cost. As the cost of checking decreases, scenario 22 
which is doing the validation in all locations becomes the best scenario and when the cost 
increases to higher values scenario 9 which is validation at warehouse picking and central 
storage receiving and scenario 3 which is validating only at warehouse picking become the best 
cases (the line above the other lines in the graph since it has lower negative expected value of 
cost). 
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Figure 17: Expected value of "time to check" with variation of cost. Branch number is the 
same as scenario number 
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Figure 18 illustrates that there is not much difference between the scenarios in terms of 
holding cost of the inventory; although, scenario 22 which is validation in every location seems 
better. 
 
Figure 18: Expected value of "average inventory" with variation of holding cost 
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Figure 19 indicates that in low costs for managing the inventory discrepancy scenario 9 
(validating only at bedside) is minimal and as the cost for that increases scenario 22 (validating 
everywhere) becomes the best case. 
 
Figure 19: Expected value of "inventory discrepancy" with variation of cost 
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 Figure 20 illustrates almost the same result as figure for average inventory and there is 
no difference between the scenarios in terms cost of transportation. 
 
Figure 20: Expected value of "number of transportation" with variation of cost 
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Figure 21 demontrates that scenario 22 has the lowest risk for patients considering all the 
risk values. 
 
Figure 21: Expected value of "waiting time" with variation of risk 
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Since the difference in waiting time of the patients’ demand are small, in lower risk rates 
there is not much difference between the scenarios in terms of waiting time but as the risk factor 
gets bigger the importance of having more validation points appears (Figure 21). 
 
Figure 22: Expected value of "total unsafe products" with variation of risk 
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4.3. CONCLUSION 
All four different systems that have been studied demonstrated that as the number of 
validation points increases the number of recalled, outdated, and misidentified products 
administered to a patient reduces (as we expect), but systems that use GS1, in most scenarios, 
have really smaller values for the total number of unsafe products that are used for patients due 
to the more accurate validation. Another thing that we can conclude is that as the validation 
points are closer to the point of use (at PAR or bedside), without using other validation points, 
the number of recalled or outdated products administered to a patient are still reduced 
significantly so checking at the bedside or PAR is critical. 
Waiting time of the patients’ demand that is another performance measure of risk is not 
affected based on the number and location of the validation points but scenarios including central 
storage picking and PAR receiving checking processes have a little bit longer average patient’s 
demand waiting time. It can be caused by amount of products that are validated in these 
locations. 
Validation at warehouse picking would help to have more accurate inventory records. 
Since doing validation at that point helps to find the misidentified products and put them at their 
correct location and correct the records, therefore, inventory records would be more accurate. 
Cost-effectiveness analysis results for average inventory (holding cost) and cost of 
transportation as variants performance measures while the other performance measures are 
constant shows that these two factors are not impacted by the location of the validation because 
the values for these two factors are really bigger than the others. For “time of checking”  as the 
cost increase while the other factors have constant cost,  validation everywhere, validation at 
only bedside, and validation at only warehouse picking are the best cases consecutively. For the 
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inventory discrepancy also when the cost increases validating only at bedside and validating 
everywhere are minimal consecutively. 
4.4. SUMMARY 
Patient safety is one of the most important health care challenges. It is a big concern since 
1 in every 10 patients around the world is affected by healthcare errors. The focus of this study is 
given to preventable adverse events that caused by the errors or system flaw that could have been 
avoided. The preventable adverse event statistics over the years reveal enormous and astonishing 
number of errors and among them supply chain-related issues are one of the major reasons in 
healthcare settings. The majority of the supply chain-related issues are caused by inventory 
discrepancy and performance deficiencies in recall, return, and outdate management at the 
provider’s level. Global Standards 1 (GS1) provides unique, unambiguous identifiers for product 
and partner/location identification is a good answer to eliminate these errors. 
In this study, simulation models are developed using Arena to evaluate the impact of GS1 
data standards on patient risk in healthcare supply chain. The focus was given to the provider 
hospital supply chain operations where inventory discrepancy and performance deficiencies in 
recall, return, and outdate management can directly affect patient safety. Simulation models are 
developed for various systems and scenarios to compare different performance measures and 
analyze the impact of GS1. The systems under the study were system includes errors in supply 
chain processes and errors in checking processes, system with errors in supply chain processes 
but no checking errors, system with only errors in checking processes, and system with no error 
in either of the supply chain and checking processes. In these systems the performance measures 
were categorized in two groups of risk related such as number of unsafe products administered to 
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a patient and patient’s demand waiting time, and system performance related such as inventory 
discrepancy, average inventory level, and number of transportation.  
The results indicates that as the validation points are closer to the point of use (at PAR or 
bedside), the number of recalled or outdated products administered to a patient are reduced 
significantly so checking at the bedside or PAR is critical. But validating products only at these 
points can cause to have a lot of unwanted outdated or recalled products remained on the shelves 
and increase the holding cost. It may also cause future problems such as running out products 
(stock outs) in emergency cases; therefore, validating in other locations is needed. The best place 
to do that based on the results is warehouse picking. It helps to have a better inventory records. 
Waiting time of the patient’s demand which is another factor of risk in our study is not affected 
by the location of the validation so overall we can say that validation at PAR or bedside and at 
warehouse picking can be the optimal case in terms of the performance measures discussed. 
 
. 
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